Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated PolioVirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants

Oliver, Sara E.; Moore, Kelly L.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated PolioVirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants

February 07 2020
By Oliver, Sara E. ; Moore, Kelly L.
Source: MMWR Morb Mortal Wkly Rep. 69(5):136-139

[PDF-86.94 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

MMWR Morb Mortal Wkly Rep
Personal Author:

Oliver, Sara E. ; Moore, Kelly L.

Oliver, Sara E. ; Moore, Kelly L. Less -
Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)Division of Bacterial Diseases.
Description:

On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and Acellular pertussis (DTaP) adsorbed, inactivated polioVirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningococcal protein conjugate) and hepatitis B (HepB) (recombinant) vaccine, DTaP-IPV-Hib-HepB (Vaxelis; MCM Vaccine Company),* for use as a 3-dose series in infants at ages 2, 4, and 6 months (1). On June 26, 2019, after reviewing data on safety and immunogenicity, the Advisory Committee on Immunization Practices (ACIP)| voted to include DTaP-IPV-Hib-HepB in the federal Vaccines for Children (VFC) program.| This report summarizes the indications for DTaP-IPV-Hib-HepB and provides guidance for its use.
Subjects:

[+]

Child, Preschool Diphtheria-Tetanus-Acellular Pertussis Vaccines Full Report Haemophilus Vaccines Hepatitis B Vaccines Humans Immunization Schedule Infant Licensure PolioVirus Vaccine, Inactivated Vaccines, Combined Vaccines, Conjugate
Source:

MMWR Morb Mortal Wkly Rep. 69(5):136-139
Pubmed ID:

32027629
Pubmed Central ID:

PMC7004397
Document Type:

Journal Article
Place as Subject:

United States
Volume:

69
Issue:

5
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha256:21c3a66febc58b7db6a9eb8ad96e91ae6e0ccf0a1913dae55a059a9c9b801f81
Download URL:

https://stacks.cdc.gov/view/cdc/85315/cdc_85315_DS1.pdf
File Type:

mm6905a5.nxml

xml

More +